Avinger, Inc. Enrolls First European PAD Patient in CONNECT II Global Clinical Trial
2/24/2012 6:30:30 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for treating patients with Peripheral Artery Disease (PAD), announces the enrollment of the first European patient in the CONNECT II global clinical trial. The first patient was enrolled this morning by Dr. Bernhard Reimers at Ospedale di Mirano in Mirano, Italy.
comments powered by